Shionogi, a leading Japanese pharmaceutical company, has joined the CMAC consortium, marking a pivotal step in global collaboration and innovation. Renowned for addressing unmet medical needs, Shionogi brings valuable regulatory insights and deep scientific expertise to CMAC’s international network.
Read More